Jakavi (ruxolintib)

pCPA File Number: 21948
Negotiation Status:
Concluded with an LOI
Indication(s):
Chronic Graft-versus-host Disease
Sponsor/Manufacturer:
Novartis Pharmaceuticals Canada Inc.
CDA-AMC Project Number:
SR0706-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: